Al Nahdi Medical Company SCJSC
SAU:4164
Balance Sheet
Balance Sheet Decomposition
Al Nahdi Medical Company SCJSC
Al Nahdi Medical Company SCJSC
Balance Sheet
Al Nahdi Medical Company SCJSC
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
121
|
170
|
372
|
1 009
|
401
|
1 076
|
910
|
957
|
|
| Cash |
121
|
170
|
172
|
1 009
|
401
|
1 076
|
149
|
957
|
|
| Cash Equivalents |
0
|
0
|
200
|
0
|
0
|
0
|
761
|
0
|
|
| Short-Term Investments |
0
|
200
|
203
|
0
|
0
|
0
|
761
|
0
|
|
| Total Receivables |
150
|
144
|
188
|
153
|
190
|
205
|
275
|
246
|
|
| Accounts Receivables |
108
|
106
|
139
|
98
|
140
|
130
|
173
|
136
|
|
| Other Receivables |
43
|
38
|
49
|
54
|
49
|
75
|
102
|
110
|
|
| Inventory |
1 227
|
1 132
|
1 134
|
1 149
|
1 116
|
1 183
|
1 409
|
1 711
|
|
| Other Current Assets |
252
|
215
|
102
|
116
|
92
|
100
|
165
|
198
|
|
| Total Current Assets |
1 750
|
1 862
|
2 000
|
2 427
|
1 799
|
2 564
|
2 759
|
3 111
|
|
| PP&E Net |
763
|
583
|
1 952
|
2 019
|
2 213
|
2 080
|
2 307
|
2 720
|
|
| PP&E Gross |
763
|
583
|
1 952
|
2 019
|
2 213
|
2 080
|
2 307
|
2 720
|
|
| Accumulated Depreciation |
413
|
526
|
974
|
753
|
860
|
950
|
1 133
|
1 362
|
|
| Intangible Assets |
45
|
40
|
35
|
41
|
44
|
47
|
51
|
69
|
|
| Long-Term Investments |
0
|
195
|
193
|
179
|
230
|
254
|
254
|
256
|
|
| Other Long-Term Assets |
14
|
9
|
7
|
0
|
0
|
0
|
0
|
18
|
|
| Total Assets |
2 571
N/A
|
2 689
+5%
|
4 186
+56%
|
4 666
+11%
|
4 287
-8%
|
4 945
+15%
|
5 371
+9%
|
6 173
+15%
|
|
| Liabilities | |||||||||
| Accounts Payable |
423
|
428
|
513
|
440
|
484
|
637
|
894
|
1 249
|
|
| Accrued Liabilities |
179
|
194
|
209
|
229
|
191
|
203
|
289
|
265
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
233
|
406
|
367
|
376
|
304
|
383
|
|
| Other Current Liabilities |
215
|
244
|
283
|
339
|
244
|
292
|
144
|
109
|
|
| Total Current Liabilities |
817
|
866
|
1 238
|
1 414
|
1 286
|
1 508
|
1 631
|
2 006
|
|
| Long-Term Debt |
2
|
2
|
984
|
829
|
992
|
792
|
871
|
1 146
|
|
| Other Liabilities |
126
|
143
|
179
|
344
|
406
|
401
|
407
|
435
|
|
| Total Liabilities |
944
N/A
|
1 010
+7%
|
2 402
+138%
|
2 587
+8%
|
2 683
+4%
|
2 702
+1%
|
2 909
+8%
|
3 587
+23%
|
|
| Equity | |||||||||
| Common Stock |
50
|
50
|
50
|
1 000
|
1 300
|
1 300
|
1 300
|
1 300
|
|
| Retained Earnings |
1 577
|
1 629
|
1 734
|
1 079
|
304
|
944
|
1 164
|
1 286
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
1 627
N/A
|
1 679
+3%
|
1 784
+6%
|
2 079
+16%
|
1 604
-23%
|
2 243
+40%
|
2 463
+10%
|
2 586
+5%
|
|
| Total Liabilities & Equity |
2 571
N/A
|
2 689
+5%
|
4 186
+56%
|
4 666
+11%
|
4 287
-8%
|
4 945
+15%
|
5 371
+9%
|
6 173
+15%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
130
|
130
|
130
|
130
|
130
|
130
|
130
|
130
|
|